Microalgal bio-economy has a promising future, yet R&D are largely underdeveloped. Our primary objective is to significantly increase the productivity of two oil-rich microalgae in synthesizing high-value products (omega-3 fatty acids and vaccines), there by lowering the production costs and enhancing product commercialization. This will be achieved by our development of fundamental molecular biotechnology for microalgae, focusing on two production species, Nannochloropsis and Phaeodactylum. Our secondary objectives are: (i) Establishment of nuclear and plastid transformation, (ii) Optimization of omega-3 fatty acid production by metabolic engineering (GMO approach) and technology-assisted breeding (non-GMO approach), and (iii) High-level expression of vaccine genes. The academic research is integrated into microalgal R&D activities involving two industrial partners (MicroA and EWOS), covering the entire value chain to fish feed production.
Mathematics, Informatics and Natural Sciences
Prof. Dr. Sigrun Reumann